Access to Health Care Press Releases
Dozens of patients from across the country, each with their own personal health care story, gathered on Capitol Hill today to urge their senators to preserve quality health care coverage for millions of Americans and reject the pending Graham-Cassidy health care legislation.
Changes to the nation’s healthcare system as proposed in the pending Graham-Cassidy health legislation could leave millions of cancer patients and survivors without access to adequate, affordable health insurance coverage, according to Dick Woodruff, senior vice president of federal advocacy for ACS CAN.
Columbus, OH – Sept. 19, 2017— Today, the American Cancer Society Cancer Action Network (ACS CAN) sent a letter to Governor Kasich calling on him to oppose a new proposal to repeal and replace the current health care law offered by Senators Graham and Cassidy.
This week the Senate HELP Committee is hearing from bipartisan health care experts in its ongoing effort to strengthen the individual insurance market and ensure that meaningful, affordable health care coverage is available for millions of Americans, including cancer patients, survivors and their families.
U.S. Senator Patty Murray (D-WA) received the National Distinguished Advocacy Award, the most esteemed award presented by the American Cancer Society Cancer Action Network (ACS CAN) for her dedication to protecting patient access to adequate and affordable health care coverage, increasing federal cancer research funding and her career-long support for policies and programs intended to end death and suffering from cancer.
Eunice Hosttetter, a breast cancer survivor from Kirkland, Wash., was honored as the State Lead Ambassador of the Year by the American Cancer Society Cancer Action Network (ACS CAN) for her commitment to cancer advocacy.
The Congressional Budget Office (CBO) today released its assessment of what would happen to health insurance premiums should the administration stop paying cost-sharing reductions (CSRs).
The CBO projects the average monthly premiums would increase 20 percent next year and 25 percent by 2020.
The Senate has advanced the U.S. Food and Drug Administration’s (FDA) Reauthorization Act, which expands four separate user fee agreements on new drugs, generic drugs, medical devices, and biosimilars, and includes a provision to maximize the development of therapies for children with cancer.
PROVIDENCE – AUGUST 3 – Rhode Island is getting mixed reviews when it comes to supporting policies and passing legislation to prevent and reduce suffering and death from cancer.
The U.S. Senate fell short of the votes needed to pass legislation that would have repealed parts of the current health care law, likely resulting in millions losing health insurance and patients paying more for less coverage.